Fortress Biotech, Inc.Fortress Biotech, Inc.Fortress Biotech, Inc.

Fortress Biotech, Inc.

No trades
See on Supercharts
Market capitalization
‪34.62 M‬USD
−21.66USD
‪−60.64 M‬USD
‪84.51 M‬USD
‪13.98 M‬
Beta (1Y)
3.60

About Fortress Biotech, Inc.

CEO
Lindsay Allan Rosenwald
Headquarters
Bay Harbor Islands
Employees (FY)
186
Founded
2006
ISIN
US34960Q3074
FIGI
BBG001J2MFH6
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of FBIO is 1.82 USD — it has increased by 1.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Fortress Biotech, Inc. stocks are traded under the ticker FBIO.
Fortress Biotech, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Fortress Biotech, Inc. has a max estimate of 24.00 USD and a min estimate of 5.00 USD.
FBIO earnings for the last quarter are −0.94 USD whereas the estimation was −3.21 USD which accounts for 70.68% surprise. Estimated earnings for the next quarter are −1.65 USD. See more details about Fortress Biotech, Inc. earnings.
Fortress Biotech, Inc. revenue for the last quarter amounts to ‪34.75 M‬ USD despite the estimated figure of ‪14.50 M‬ USD. In the next quarter revenue is expected to reach ‪15.12 M‬ USD.
Yes, you can track Fortress Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, FBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fortress Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
FBIO reached its all-time high on Apr 23, 2013 with the price of 190.40 USD, and its all-time low was 1.24 USD and was reached on Nov 10, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 186.00 employees. See our rating of the largest employees — is Fortress Biotech, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fortress Biotech, Inc. EBITDA is ‪−132.22 M‬ USD, and current EBITDA margin is −155.20%. See more stats in Fortress Biotech, Inc. financial statements.